BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grim C, Noble R, Uribe G, Khanipov K, Johnson P, Koltun WA, Watts T, Fofanov Y, Yochum GS, Powell DW, Beswick EJ, Pinchuk IV. Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's Disease. J Crohns Colitis 2021;15:1362-75. [PMID: 33506258 DOI: 10.1093/ecco-jcc/jjab001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ito G, Yui S, Okamoto R. A Cellular "Hub" Function to Resolve Colitis. Cell Mol Gastroenterol Hepatol 2021;12:789-90. [PMID: 33971162 DOI: 10.1016/j.jcmgh.2021.04.008] [Reference Citation Analysis]
2 Qi LL, Fan ZY, Mao HG, Wang JB. The Therapeutic Efficacy of Adipose Tissue-Derived Mesenchymal Stem Cell Conditioned Medium on Experimental Colitis Was Improved by the Serum From Colitis Rats. Front Bioeng Biotechnol 2021;9:694908. [PMID: 34604183 DOI: 10.3389/fbioe.2021.694908] [Reference Citation Analysis]
3 Huldani H, Margiana R, Ahmad F, Opulencia MJC, Ansari MJ, Bokov DO, Abdullaeva NN, Siahmansouri H. Immunotherapy of inflammatory bowel disease (IBD) through mesenchymal stem cells. International Immunopharmacology 2022;107:108698. [DOI: 10.1016/j.intimp.2022.108698] [Reference Citation Analysis]
4 Wu Q, Xie S, Zhu Y, Chen J, Tian J, Xiong S, Wu C, Ye Y, Peng Y. Wogonin Strengthens the Therapeutic Effects of Mesenchymal Stem Cells in DSS-Induced Colitis via Promoting IL-10 Production. Oxid Med Cell Longev 2021;2021:5527935. [PMID: 34239686 DOI: 10.1155/2021/5527935] [Reference Citation Analysis]